Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Olverembatinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06082934
What this trial is testing

Olverembatinib Plus Venetoclax and Dexamethasone for Treatment-naïve Ph+ Acute Lymphoblastic Leukemia

Who this might be right for
Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia
Xijing Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT05521204
What this trial is testing

Olverembatinib for FGFR1-rearranged Neoplasms

Who this might be right for
Myeloproliferative NeoplasmAcute Leukemia
The First Affiliated Hospital of Soochow University 20
Large-scale testing (Phase 3)UnknownNCT05311943
What this trial is testing

Treatment With Olverembatinib in CML-CP Patients Who Failed to at Least Two Previously Administered Second-generation TKIs.

Who this might be right for
OlverembatinibChronic Myeloid Leukemia, Chronic PhaseTyrosine Kinase Inhibitors
Shenzhen Second People's Hospital 40
Large-scale testing (Phase 3)Looking for participantsNCT06051409
What this trial is testing

Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

Who this might be right for
Ph+ ALLLeukemia, Lymphoblastic, Acute, Philadelphia-Positive
Ascentage Pharma Group Inc. 350
Early research (Phase 1)Looking for participantsNCT07282093
What this trial is testing

Pharmacokinetics of Olverembatinib in Participants With Hepatic Impairment

Who this might be right for
PharmacokineticOlverembatinib
Ascentage Pharma Group Inc. 48
Testing effectiveness (Phase 2)Study completedNCT05594784
What this trial is testing

Olverembatinib Combined With Reduced-Intensity Chemotherapy and Venetoclax for de Novo Ph+ ALL

Who this might be right for
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 79
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07178912
What this trial is testing

Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Phase II Clinical TrialBlinatumomabOlverembatinib+2 more
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT04126681
What this trial is testing

A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic Phase

Who this might be right for
Chronic Myeloid Leukemia, Chronic Phase
Ascentage Pharma Group Inc. 144